Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds

Cancer Research

Volumn 57, Issue 21, 1997, Pages 4757-4764

  Shimada, Tsutomu ^a   El Bayoumy, Karam ^b   Upadhyaya, Pramod ^b   Sutter, Thomas R ^c   Guengerich, F Peter ^d   Yamazaki, Hiroshi ^a  

^a OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^b AMERICAN HEALTH FOUNDATION   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 PHENYLENE BIS(METHYLENE)SELENOCYANATE; 1,3 PHENYLENE BIS(METHYLENE)SELENOCYANATE; 1,4 PHENYLENEBIS(METHYLENE)SELENOCYANATE; 2 FLUORENYLAMINE; 7 ETHOXYCOUMARIN; ANTHRACENE DERIVATIVE; BENZYL SELENOCYANATE; BETA NAPHTHOFLAVONE; BUFURALOL; CHLORZOXAZONE; COUMARIN; CYTOCHROME P450; DIBENZYLDISELENIDE; ETHOXYRESORUFIN; ORGANOSELENIUM DERIVATIVE; TESTOSTERONE; UNCLASSIFIED DRUG; WARFARIN;

ANIMAL CELL; ARTICLE; CANCER PREVENTION; DNA DAMAGE; HUMAN; HUMAN CELL; INHIBITION KINETICS; LIVER MICROSOME; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; REACTION ANALYSIS; SPECTRAL SENSITIVITY; STRAIN DIFFERENCE; XENOBIOTIC METABOLISM;

ANIMALS; ANTHRACENES; ANTICARCINOGENIC AGENTS; BENZYL COMPOUNDS; CARCINOGENS; CYANATES; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; MALE; MICROSOMES; MICROSOMES, LIVER; ORGANOSELENIUM COMPOUNDS; OXAZINES; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; SACCHAROMYCES CEREVISIAE; SALMONELLA TYPHIMURIUM; SODIUM SELENITE; XENOBIOTICS;

EID: 0030815247     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Willett, W. C., Polk, B. F., Morris, J. S., Stampfer, M. J., Pressel, S., Rosner, B., Taylor, J. O., Schneider, K., and Hames, C. G. Prediagnostic serum selenium and risk of cancer. Lancet, 16: 130-133, 1983.
2. Clark, L. C., Cantor, K., P., and Allaway, W. H. Selenium in forage crops and cancer mortality in U. S. counties. Arch. Environ. Health, 46: 37-42, 1991.
3. Bertram, J. S., Kolonel, L. N., and Meyskens, F. L. Rationale and strategies for chemoprevention of cancer in humans. Cancer Res., 47: 3012-3031, 1987.
4. Malone, W. F., and Kelloff, G. J. Chemoprevention strategies utilizing combinations of inhibitors of carcinogenesis. J. Natl. Cancer Inst., 81: 839-843, 1989.
5. El-Bayoumy, K. The role of selenium in cancer prevention. In: V. DeVita, S. Hellman, and S. A. Rosenberg (eds.), Cancer Principles and Practice of Oncology, Ed. 4, pp. 1-15, Philadelphia: J. B. Lippincott, 1991.
6. Ip, C. Selenium and experimental cancer. Ann. Clin. Res., 18: 22-29, 1986.
7. Ip, C., and Medina, D. Current concepts of selenium and mammary tumorigenesis, In: D. Medina, W. Kidwell, G. H. Heppner, and E. Anderson (eds.), Cellular and Molecular Biology of Mammary Cancer, pp. 479-494. New York: Plenum Publishing Corp., 1987.
8. Medina, D., and Morrison, D. G. Current ideas on selenium as a chemopreventive agent. Pathol. Immunopathol. Res., 7: 187-199, 1988.
9. El-Bayoumy, K., Chae, Y-H., Upadhyaya, P., Meschter, C., Cohen, L. A., and Reddy, B. S. Inhibition of 7,12-dimethylbenzo[a]anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate. Cancer Res., 52: 2402-2407, 1992.
10. Ip, C., El-Bayoumy, K., Upadhyaya, P., Ganther, H., Vadhanavikit, S., and Thompson, H. Comparative effect of inorganic and organic selenocyanate derivatives in mammary cancer chemoprevention. Carcinogenesis (Lond.), 15: 187-192, 1994.
11. Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., Gunsalus, I. C., and Nebert, D. W. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6: 1-12, 1996.
12. Pelkonen, O., and Nebert, D. W. Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol. Rev., 34: 189-222, 1982.
13. Dipple, A., and Bigger, C. A. H. Mechanism of action of food-associated polycyclic aromatic hydrocarbon carcinogens. Mutat. Res., 259: 263-276, 1991.
14. Guengerich, F. P., and Shimada, T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol., 4: 391-407, 1991.
15. Gonzalez, F. J., and Gelboin, H. V. Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab. Rev., 26: 165-183, 1994.
16. Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, F. P., and Sutter, T. R. Activation of chemically diverse procarcinogens by human cytochrome P450 1B1. Cancer Res., 56: 2979-2984, 1996.
17. Sutter, T. R., Tang, Y. M., Hayes, C. L., Wo, Y-Y. P., Jabs, W., Li, X., Yin, H., Cody, C. W., and Greenlee, W. F. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J. Biol. Chem., 269: 13092-13099, 1994.
18. Amin, S., Krzeminski, J., Rivenson, A., Kurtzke, C. Hecht, S. S., and El-Bayoumy, K. Mammary carcinogenicity in female CD rats of fjord region diol epoxides of benzo[c]phenanthrene, benzo[g]chrysene and dibenzo[a,l]pyrene. Carcinogenesis (Lond.), 16: 1971-1974, 1995.
19. Hecht, S. S., El-Bayoumy, K., Rivenson, A., and Amin, S. Potent mammary carcinogenicity in female CD rats of a fjord region diol-epoxide of benzo[c]phenanthrene compared to a bay region diol-epoxide of benzo[a]pyrene. Cancer Res., 54: 21-24, 1995.
20. El-Bayoumy, K., Upadhyaya, P., Chae, Y-H., Sohn, O-S., Rao, C. V., Faila, E., and Reddy, B. S. Chemoprevention of cancer by organoselenium compounds. J. Cell Biochem. Suppl., 22: 92-100, 1995.
21. Shimada, T., Iwasaki, M., Martin, M. V., and Guengerich, F. P. Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA1535/pSK1002. Cancer Res., 49: 3218-3228, 1989.
22. Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., and Guengerich, F. P. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther., 270: 414-423, 1994.
23. Yamazaki, H., Guo, Z., Persmark, M., Mimura, M., Inoue, K., Guengerich, F. P., and Shimada, T. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes. Mol. Pharmacol., 46: 568-577, 1994.
24. Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. C., Walker, N. J., and Sutter, T. R. 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl. Acad. Sci. USA, 93: 9776-9781, 1996.
25. Guo, Z., Gillam, E., Ohmori, S., Tukey, R. H., and Guengerich, F. P. Expression of modified human cytochrome P450 1A1 in Escherichia coli: effects of 5′ substitution, stabilization, purification, spectral characterization, and catalytic properties. Arch. Biochem. Biophys., 312: 436-446, 1994.
26. Sandhu, P., Guo, Z., Baba, T., Martin, M. V., Tukey, R. H., and Guengerich, F. P. Expression of modified human cytochrome P450 1A2 in Escherichia coli. Stabilization, purification, spectral characterization, and catalytic activities of the enzymes. Arch. Biochem. Biophys., 309: 168-177, 1994.
27. Yasukochi, Y., and Masters, B. S. S. Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography. J. Biol. Chem., 251: 5337-5344, 1976.
28. Taniguchi, H., Imai, Y., Iyanagi, T., and Sato, R. Interaction between NADPH-cytochrome P-450 reductase and cytochrome P-450 in the membrane of phosphatidylcholine vesicles. Biochim. Biophys. Acta, 550: 341-356, 1979.
29. Guengerich, F. P. Analysis and characterization of enzymes. In: A. W. Hayes (ed.), Principles and Methods of Toxicology, Ed. 3, pp. 1259-1313. New York: Raven Press, 1994.
30. Shimada, T., Gillam, E. M. J., Sutter, T. R., Strickland, P. T., Guengerich, F. P., and Yamazaki, H. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1. Drug Metab. Dispos., 25: 617-622, 1997.
31. Shimada, T., and Nakamura, S. Cytochrome P-450-mediated activation of procarcinogens and promutagens to DNA-damaging products by measuring expression of umu gene in Salmonella typhimurium TA1535/pSK1002. Biochem. Pharmacol., 36: 1979-1987, 1987.
32. Yamazaki, H., Mimura, M., Sugahara, C., and Shimada, T. Catalytic roles of rat and human cytochrome P450 2A enzymes in testosterone 7α-and coumarin 7-hydroxylations. Biochem. Pharmacol., 48: 1524-1527, 1994.
33. Kronbach, T., Mathys, D., Gut, J., Catin, T., and Meyer, U. A. High-performance liquid chromatographic assays for bufuralol 1′-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver. Anal. Biochem., 162: 24-32, 1987.
34. Lang, D., and Böcker, R. Highly sensitive and specific high-performance liquid chromatographic analysis of 7-hydroxywarfarin, a marker for human cytochrome P-4502C9 activity. J. Chromatogr. Biomed. Appl., 672: 305-309, 1995.
35. 5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes. Biochem. Pharmacol., 52: 301-309, 1996.
36. 5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. Arch. Biochem. Biophys., 325: 174-182, 1996.
37. Shimada, T., Martin, M. V., Pruess-Schwartz, D., Marnett, L. J., and Guengerich, F. P. Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. Cancer Res., 49: 6304-6312, 1989.
38. Omura, T., and Sato, R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem., 239: 2370-2378, 1964.
39. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193: 265-275, 1951.
40. Shimada, T., and Okuda, Y. Metabolic activation of environmental carcinogens and mutagens by human liver microsomes: role of cytochrome P-450 homologous to a 3-methylcholanthrene-inducible isozyme in rat liver. Biochem. Pharmacol., 37: 459-465, 1988.
41. Sutter, T. R., Guzman, K., Dold, K. M., and Greenlee, W. F. Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1β. Science (Washington DC), 254: 415-418, 1995.
42. Shen, Z., Liu, J., Wells, R. L., and Elkind, M. M. cDNA cloning, sequence analysis, and induction by aryl hydrocarbons of a murine cytochrome P450 gene, Cyp1b1. DNA Cell Biol., 13: 763-769, 1994.
43. Savas, Ü., Bhattacharyya, K. K., Christou, M., Alexander, D. L., and Jefcoate, C. R. Mouse cytochrome P-450EF. representative of a new 1B subfamily of cytochrome P-450s. J. Biol. Chem., 209: 14905-14911, 1994.
44. Bhattacharyya, K. K., Brake, P. B., Eltom, S. E., Otto, S. A., and Jefcoate, C. R. Identification of a rat adrenal cytochrome P450 active in polycyclic hydrocarbon metabolism as rat CYP1B1. J. Biol. Chem., 270: 11595-11602, 1995.
45. Walker, N. J., Gastel, J. A., Costa, L. T., Clark, G. C., Lucier, G. W., and Sutter, T. R. Rat CYP1B1: an adrenal cytochrome P450 that exhibits sex dependent expression in livers and kidneys of TCDD-treated animals. Carcinogenesis (Lond.), 16: 1319-1327, 1995.
46. Otto, S., Marcus, C., Pidgeon, C., and Jefcoate, C. A novel adrenocorticotropin-inducible cytochrome P450 from rat adrenal microsomes catalyzes polycylic aromatic hydrocarbon metabolism. Endocrinology, 129: 970-982, 1991.
47. Otto, S., Bhattacharyya, K. K., and Jefcoate, C. R. Polycyclic aromatic hydrocarbon metabolism in rat adrenal, ovary, and testis microsomes is catalyzed by the same novel cytochrome P450 (P450RAP). Endocrinology, 131: 3067-3076, 1992.
48. Pottenger, L. H., Christou, M., and Jefcoate, C. R. Purification and immunological characterization of a novel cytochrome P450 from C3H/10T1/2 cells. Arch. Biochem. Biophys., 286: 488-497, 1991.
49. Melikian, A. A., Amin, S., Huie, K., Hecht, S. S., and Harvey, R. G. Reactivity with DNA bases and mutagenicity toward Salmonella typhimurium of methylchrysene diol epoxide enantiomers. Cancer Res., 48: 1781-1787, 1995.
50. Ioannides, C., and Parke, D. V. The cytochrome P-450 1 gene family of microsomal hemoproteins and their role in the metabolic activation of chemicals. Drug Metab. Rev., 22: 1-85, 1990.
51. Shimada, T., Yun, C. H., Yamazaki, H., Gautier, J. C., Beaune, P. H., and Guengerich, F. P. Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol. Pharmacol., 41: 856-864, 1992.
52. Tjia, J. F., Colbert, J., and Back, D. J. Theophylline metabolism in human liver microsomes: inhibition studies. J. Pharmacol. Exp. Ther., 276: 912-917, 1996.
53. Imaoka, S., Enomoto, K., Oda, Y., Asada, A., Fujimori, M., Shimada, T., Fujita, S., Guengerich, F. P., and Funae, Y. Lidocaine metabolism by human cytochrome P-450s purified from hepatic microsomes: comparison of those with rat hepatic cytochrome P-450s. J. Pharmacol. Exp. Ther., 255: 1385-1391, 1990.
54. PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. USA, 86: 7696-7700, 1989.
55. Ganther, H. Selenium metabolism and function in man and animals. In: P. Brutter and P. Schramel (eds.), Trace Element-Analytical Chemistry in Medicine and Biology, Vol. 3, pp. 3-24. Berlin, Germany: Walter de Gruyter, 1984.
56. 14C]1,4-phenylenebis(methylene)selenocyanate, a chemopreventive organosclenium compound, in female CD rats. Am. Assoc. Cancer Res., 37: 1876, 1996.
57. Hecht, S. S. Metabolic activation and detoxification of tobacco-specific nitrosamines: a model for cancer prevention strategies. Drug Metab. Rev., 26: 373-390, 1997.